Nutcracker Therapeutics
As Executive Vice President, General Counsel, Ian Wiener leads Nutcracker's legal function and advises the board and management on legal, business and policy matters. Prior to joining Nutcracker, Ian was a partner at the law firm of Irell & Manella LLP, representing corporate, private equity and other clients in a wide variety of business law matters and complex business transactions. Ian was awarded a B.A. in Economics from Dartmouth College and a J.D. from Georgetown University Law Center.
This person is not in any offices
Nutcracker Therapeutics
Nutcracker Therapeutics is an early-stage biotech disrupter founded to develop mRNA-based therapeutic drug products which will be manufactured on the novel ACORN (Automation COntroled RNA) microfluidic-based manufacturing system.